| 000 | 01718 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515190721.0 | ||
| 264 | 0 | _c20100525 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1556-5653 | ||
| 024 | 7 |
_a10.1016/j.fertnstert.2009.08.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBodri, Daniel | |
| 245 | 0 | 0 |
_aEarly ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study. _h[electronic resource] |
| 260 |
_bFertility and sterility _cMay 2010 |
||
| 300 |
_a2418-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLuteal Phase _xdrug effects |
| 650 | 0 | 4 |
_aMenotropins _xadministration & dosage |
| 650 | 0 | 4 |
_aOocyte Donation _xmethods |
| 650 | 0 | 4 |
_aOvarian Hyperstimulation Syndrome _xetiology |
| 650 | 0 | 4 |
_aOvulation Induction _xmethods |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGuillén, Juan José | |
| 700 | 1 | _aTrullenque, Marta | |
| 700 | 1 | _aSchwenn, Katja | |
| 700 | 1 | _aEsteve, Carolina | |
| 700 | 1 | _aColl, Oriol | |
| 773 | 0 |
_tFertility and sterility _gvol. 93 _gno. 7 _gp. 2418-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.fertnstert.2009.08.036 _zAvailable from publisher's website |
| 999 |
_c19195976 _d19195976 |
||